MedTrace Logo

THRIVE in Pediatric Laryngeal Microsurgery

NCT03241979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-04-21

No results posted yet for this study

Summary

Transnasal High-flow rapid-insufflation ventilatory exchange (THRIVE) has been shown to benefit oxygenation, ventilation and upper airway patency in a range of clinical scenarios, however its use in spontaneously breathing pediatric patients undergoing tubeless airway surgery has not been described. This is a physiologic study that evaluates the feasibility of THRIVE during pediatric airway surgery under self-respiration.

Conditions

  • Laryngoscopy

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2019-06-03
Completion
2019-06-03

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241979 on ClinicalTrials.gov